Investigation of the visibility of the esophagogastric junction in esophagogastroduodenoscopy using sedation by pethidine alone.

Investigation of the visibility of the esophagogastric junction in esophagogastroduodenoscopy using sedation by pethidine alone. - Investigation of the visibility of the esophagogastric junction in esophagogastroduodenoscopy using sedation by pethidine alone.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036411

Enrollment

400

Registered

2019-04-05

Start date

2019-02-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

none

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Participants who underwent esophagogastroduodenoscopic screening with pethidine alone sedation or without sedation.

Exclusion criteria

Exclusion criteria: Participants who received sedation other than pethidine alone.

Design outcomes

Primary

Measure	Time frame
visibility of the esophagogastric junction	—

Countries

Japan

Contacts

Public ContactKenichiro Majima

Kameda Medical Center Department of Health Management

maji-ken@umin.ac.jp04-7092-2211

Outcome results